Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock

被引:3
|
作者
Somaschini, Alberto [1 ,2 ]
Cornara, Stefano [1 ,2 ]
Leonardi, Sergio [2 ,3 ]
Demarchi, Andrea [2 ,4 ]
Mandurino-Mirizzi, Alessandro [2 ,5 ]
Fortuni, Federico [2 ]
Ferlini, Marco [3 ]
Crimi, Gabriele [6 ]
Camporotondo, Rita [3 ]
Gnecchi, Massimiliano [2 ,7 ]
Visconti, Luigi [3 ]
De Servi, Stefano [2 ]
De Ferrari, Gaetano Maria [8 ,9 ]
机构
[1] San Paolo Hosp, Div Cardiol, Cardiac Intens Care Unit, I-17100 Savona, Italy
[2] Univ Pavia, Dept Mol Med, Unit Cardiol, I-27100 Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[4] Ente Osped Cantonale, Cardioctr Ticino Inst, CH-6900 Lugano, Switzerland
[5] V Fazzi Hosp, Div Cardiol, I-73100 Lecce, Italy
[6] IRCCS Osped Policlin San Martino, CardioThoraco Vasc Dept DICATOV, Intervent Cardiol Unit, I-16132 Genoa, Italy
[7] Fdn IRCCS Policlin San Matteo, Cardiol Traslaz, I-27100 Pavia, Italy
[8] Citta Salute & Sci Hosp, Cardiovasc & Thorac Dept, Div Cardiol, I-10126 Turin, Italy
[9] Univ Turin, Dept Med Sci, I-10126 Turin, Italy
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 10期
关键词
acute myocardial infarction; cardiogenic shock; mechanical circulatory support; IABP; INTRAAORTIC BALLOON PUMP; ST-SEGMENT ELEVATION; CIRCULATORY SUPPORT; COUNTERPULSATION; CORONARY; MANAGEMENT; TRIAL;
D O I
10.3390/medicina59101806
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives. Recent guidelines have downgraded the routine use of the intra-aortic balloon pump (IABP) in patients with cardiogenic shock (CS) due to ST-elevation myocardial infarction (STEMI). Despite this, its use in clinical practice remains high. The aim of this study was to evaluate the prognostic impact of the IABP in patients with STEMI complicated by CS undergoing primary PCI (pPCI), focusing on patients with anterior MI in whom a major benefit has been previously hypothesized. Materials and Methods. We enrolled 2958 consecutive patients undergoing pPCI for STEMI in our department from 2005 to 2018. Propensity score matching and mortality analysis were performed. Results. CS occurred in 246 patients (8.3%); among these patients, 145 (60%) had anterior AMI. In the propensity-matched analysis, the use of the IABP was associated with a lower 30-day mortality (39.3% vs. 60.9%, p = 0.032) in the subgroup of patients with anterior STEMI. Conversely, in the whole group of CS patients and in the subgroup of patients with non-anterior STEMI, IABP use did not have a significant impact on mortality. Conclusions. The use of the IABP in cases of STEMI complicated by CS was found to improve survival in patients with anterior infarction. Prospective studies are needed before abandoning or markedly limiting the use of the IABP in this clinical setting.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Burden of Arrhythmias in Acute Myocardial Infarction Complicated by Cardiogenic Shock
    Vallabhajosyula, Saraschandra
    Patlolla, Sri Harsha
    Verghese, Dhiran
    Ya'Qoub, Lina
    Kumar, Vinayak
    Subramaniam, Anna, V
    Cheungpasitporn, Wisit
    Sundaragiri, Pranathi R.
    Noseworthy, Peter A.
    Mulpuru, Siva K.
    Bell, Malcolm R.
    Gersh, Bernard J.
    Deshmukh, Abhishek J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (12): : 1774 - 1781
  • [32] CORONARY ANGIOGRAPHY IN CARDIOGENIC SHOCK COMPLICATED WITH ACUTE MYOCARDIAL INFARCTION
    Guo Ruiwei
    Yanglixia
    HEART, 2013, 99 : E166 - E167
  • [33] Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock
    Vergara, Ruben
    Valenti, Renato
    Migliorini, Angela
    Parodi, Guido
    Giurlani, Letizia
    Marrani, Marco
    Cantini, Giulia
    Antoniucci, David
    JOURNAL OF INVASIVE CARDIOLOGY, 2016, 28 (12): : E193 - E197
  • [34] Interventional therapies in acute myocardial infarction complicated by cardiogenic shock
    de Waha, S.
    Desch, S.
    Fuernau, G.
    Poess, J.
    Ledwoch, J.
    Jobs, A.
    Eitel, I.
    Thiele, H.
    HERZ, 2017, 42 (01) : 11 - 17
  • [35] Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the IABP-SHOCK II-Trial
    Poess, Janine
    Fuernau, Georg
    Denks, Daniel
    Desch, Steffen
    Eitel, Ingo
    de Waha, Suzanne
    Link, Andreas
    Schuler, Gerhard
    Adams, Volker
    Boehm, Michael
    Thiele, Holger
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (11) : 1152 - 1160
  • [36] HEMODYNAMIC IMPROVEMENT FOLLOWING LEVOSIMENDAN TREATMENT IN ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK PATIENTS TREATED WITH PRIMARY PCI AND IABP
    Mancone, Massimo
    Pennacchi, Mauro
    Lucisano, Luigi
    Calcagno, Simone
    D'Ambrosi, Alessandra
    Marceca, Azzurra
    Bruno, Noemi
    Brasolin, Bruno
    Sardella, Gennaro
    Fedele, Francesco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E770 - E770
  • [37] Fibroblast Growth Factor 23 in Acute Myocardial Infarction Complicated by Cardiogenic Shock - A Biomarker Substudy of the IABP-SHOCK II-trial
    Fuernau, Georg
    Poess, Janine
    Denks, Daniel
    Desch, Steffen
    Heine, Gunner H.
    Eitel, Ingo
    Seiler, Sarah
    de Waha, Suzanne
    Link, Andreas
    Schuler, Gerhard C.
    Adams, Volker
    Boehm, Michael
    Thiele, Holger
    CIRCULATION, 2013, 128 (22)
  • [38] Course and prognostic impact of different inflammation markers in myocardial infarction complicated by cardiogenic shock - a biomarker substudy of the IABP-SHOCK II trial
    Fuernau, G.
    Traeder, F.
    Eitel, I.
    Desch, S.
    De Waha, S.
    Schuler, G.
    Adams, V.
    Werdan, K.
    Zeymer, U.
    Thiele, H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 234 - 234
  • [39] Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial
    Fuernau, G.
    Poess, J.
    Denks, D.
    Desch, S.
    Heine, G.
    Eitel, I.
    de Waha, S.
    Schuler, G.
    Adams, V.
    Boehm, M.
    Thiele, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S6 - S6
  • [40] Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial
    Fuernau, G.
    Poess, J.
    Denks, D.
    Desch, S.
    Heine, G.
    Eitel, I.
    de Waha, S.
    Schuler, G.
    Adams, V.
    Boehm, M.
    Thiele, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S6 - S6